Search research articles
Contact Us
Filters
Showing results (1-10 of 95) with videos related to
Page
of 10
Sort By:
Expert Review of Gastroenterology & Hepatology
|
January 11, 2020
Trifluridine/tipiracil for the treatment of metastatic gastric cancer
Akihito Kawazoe, Kohei Shitara
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 16, 2017
[Cytotoxic Agents and Immune Checkpoint Inhibitors]
Akihito Kawazoe, Kohei Shitara
Therapeutic Advances in Medical Oncology
|
July 2, 2019
Next-generation sequencing and biomarkers for gastric cancer: what is the future?
Akihito Kawazoe, Kohei Shitara
Expert Opinion on Drug Safety
|
August 4, 2020
Safety of pembrolizumab in recurrent or advanced gastric cancer expressing PD-L1 refractory to platinum and fluoropyrimidine
Saori Mishima, Akihito Kawazoe, Kohei Shitara
International Journal of Clinical Oncology
|
April 13, 2019
Dawn of precision medicine on gastric cancer
Takahiro Ishii, Akihito Kawazoe, Kohei Shitara
Cancers
|
February 25, 2022
The New Era of Immunotherapy in Gastric Cancer
Shogo Takei, Akihito Kawazoe, Kohei Shitara
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 18, 2024
[Chemotherapy for Unresectable Advanced, Metastatic or Recurrent Colorectal Cancer]
Yu Miyashita, Akihito Kawazoe, Takayuki Yoshino
Expert Review of Anticancer Therapy
|
February 5, 2026
An evaluation of pembrolizumab with trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy for HER2 positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1 (CPS ≥1)
Kyosuke Seguchi, Akihito Kawazoe, Izuma Nakayama, et al.
Cancer Management and Research
|
October 24, 2022
Role of Nivolumab in the Management of First-Line Unresectable Advanced or Recurrent Gastric Cancer in Combination with Chemotherapy: Lessons from the Japanese Experience
Yohei Kubota, Yu Aoki, Akihito Kawazoe, et al.
Japanese Journal of Clinical Oncology
|
November 26, 2020
Current status of immunotherapy for advanced gastric cancer
Akihito Kawazoe, Kohei Shitara, Narikazu Boku, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 95) with videos related to
Sort By:
Page
of 10
Expert Review of Gastroenterology & Hepatology
|
January 11, 2020
Trifluridine/tipiracil for the treatment of metastatic gastric cancer
Akihito Kawazoe, Kohei Shitara
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 16, 2017
[Cytotoxic Agents and Immune Checkpoint Inhibitors]
Akihito Kawazoe, Kohei Shitara
Therapeutic Advances in Medical Oncology
|
July 2, 2019
Next-generation sequencing and biomarkers for gastric cancer: what is the future?
Akihito Kawazoe, Kohei Shitara
Expert Opinion on Drug Safety
|
August 4, 2020
Safety of pembrolizumab in recurrent or advanced gastric cancer expressing PD-L1 refractory to platinum and fluoropyrimidine
Saori Mishima, Akihito Kawazoe, Kohei Shitara
International Journal of Clinical Oncology
|
April 13, 2019
Dawn of precision medicine on gastric cancer
Takahiro Ishii, Akihito Kawazoe, Kohei Shitara
Cancers
|
February 25, 2022
The New Era of Immunotherapy in Gastric Cancer
Shogo Takei, Akihito Kawazoe, Kohei Shitara
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 18, 2024
[Chemotherapy for Unresectable Advanced, Metastatic or Recurrent Colorectal Cancer]
Yu Miyashita, Akihito Kawazoe, Takayuki Yoshino
Expert Review of Anticancer Therapy
|
February 5, 2026
An evaluation of pembrolizumab with trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy for HER2 positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1 (CPS ≥1)
Kyosuke Seguchi, Akihito Kawazoe, Izuma Nakayama, et al.
Cancer Management and Research
|
October 24, 2022
Role of Nivolumab in the Management of First-Line Unresectable Advanced or Recurrent Gastric Cancer in Combination with Chemotherapy: Lessons from the Japanese Experience
Yohei Kubota, Yu Aoki, Akihito Kawazoe, et al.
Japanese Journal of Clinical Oncology
|
November 26, 2020
Current status of immunotherapy for advanced gastric cancer
Akihito Kawazoe, Kohei Shitara, Narikazu Boku, et al.
Page
of 10